Peter P. Pfreundschuh, Chief Financial Officer at UroGen Pharma Ltd. (URGN), sold 360 shares at $29.68 ($11K) on 2020-02-20, disclosed to the SEC on 2020-02-24.
Open-market sale of $11k URGN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| FREQ | SELL | 2022-02-23 | $11K | — | Filing → |
| FREQ | SELL | 2022-02-18 | $11K | — | Filing → |
| FREQ | SELL | 2022-02-16 | $6K | — | Filing → |